5-Aug-2025 Waterways—Past, Present and Future continues to teach University of British Columbia Okanagan campus An art installation, featuring interactive 3D virtual panels that share Syilx teachings about human and water relationships and values, continues to be used as a teaching tool years after it was first inspired. Dr. Aleksandra Dulic, Visual Arts Professor in UBC Okanagan’s Faculty of Creative and Critical Studies, is the artistic director behind Waterways—Past, Present and Future. Journal Social Sciences & Humanities Open
5-Aug-2025 New excavation campaign at Trou Al'Wesse, tracing the settlement of Homo sapiens in our regions University of Liège Archaeologists from the University of Liège (Belgium) are conducting a new excavation campaign at the Palaeolithic site of Trou Al'Wesse in Modave. This exceptional site provides valuable information about the settlement of the first Homo sapiens populations in north-western Europe around 40,000 years ago. It is also an opportunity for archaeology students to gain practical experience in the field.
4-Aug-2025 Medium-voltage circuit breaker unlocks electricity abundance, savings DOE/Oak Ridge National Laboratory Researchers at the Department of Energy’s Oak Ridge National Laboratory are breaking technical barriers with faster circuit breakers to enable and protect the modern electric grid. The ORNL team developed medium-voltage circuit breakers capable of handling increasing levels of direct current at a lower cost, an advance that can help reduce future electricity costs and expand capacity in an overburdened U.S. grid.
4-Aug-2025 KIER successfully hosts the 4th Korea-Canada battery R&D workshop National Research Council of Science & Technology The Korea Institute of Energy Research (KIER, President Yi, Chang-Keun) hosted the 4th Korea-Canada Battery R&D Workshop in Montreal, Canada, over two days on Tuesday, July 29 and Wednesday, July 30, 2025. Funder Ministry of Science and ICT
4-Aug-2025 Behind the Science: Ribosomes, the protein factories of cells Stanford Medicine New tools reveal how ribosomes — the cell’s protein factories — specialize in ways that could unlock treatments for cancer, neurodegenerative diseases, and more. Maria Barna and team are digging deep.
1-Aug-2025 The power of play in early childhood Texas A&M University Experts at the Texas A&M University Institute for Early Childhood Development and Education provide tips for parents on how to use play to help young children make sense of the world.
1-Aug-2025 Astronomers use starlight to measure greenhouse gases University of Warwick University of Warwick astronomers, in partnership with institutions in Spain, are showing how astronomy tools, that are usually used to study stars, can be repurposed as climate sensors, helping us track how Earth's atmosphere is changing in the face of global warming.
1-Aug-2025 Non-smokers account for 20% of lung cancer diagnoses BGI Genomics Almost five new cases of lung cancer are diagnosed every minute globally and one of them would be a non-smoker. Screening gap remains one of the critical challenges of lung cancer prevention as most of the current screening programs are offered to smokers. Genetic testing provides an alternative screening option to identify genetic mutations before symptoms appear, saving a time window for timely treatment.
1-Aug-2025 Chikungunya cases surge sixfold in South China city in a week BGI Genomics Transmission dynamics are complicated by mosquitoes' ability to carry multiple viruses simultaneously. For complex infections that may involve multiple viruses and pathogens, metagenomics next-generation sequencing (mNGS) technology is a more comprehensive approach. It offers in-depth reports for rapid and accurate detection.
1-Aug-2025 HKUMed launches world-leading gene-related therapy clinical trials to eradicate chronic hepatitis B infection The University of Hong Kong Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have initiated multiple clinical trials exploring pioneering gene-related therapy for chronic hepatitis B infection, potentially allowing patients to discontinue long-term medication. This positions HKUMed as one of only three global sites conducting these groundbreaking trials, alongside counterparts in Europe and New Zealand.
